Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022

Questions: Discounts, Updates etc.

Pages: 101

Price (Single): £1699

Price (Departmental): £2999

Price (Company): £6999

Publication Date: 2012-05-01

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022 - offers a comprehensive view of the global nuclear medicine imaging systems market. The report analyses recent trends in this market and anticipates the progression in the market over the next decade with global, regional and submarket forecasts. The report also reveals the market's strengths and weaknesses, revealing areas that will experience growth and present new business opportunities. The report predicts  the global value of the nuclear medicine imaging systems market in 2011 to be worth $1.5bn. Growth in this market will be driven by new technology and varied uses of the technology.

Despite experiencing a decline in sales volume and reduced demand in the aftermath of the global economic recession, the nuclear medicine market recovered well, and has seen strong growth in recent years. Much of this growth has been linked to the advent of hybrid units, such as positron emission tomography/computed tomography (PET/CT) scans, where both anatomical and functional images can be captured. For example, the combination of Positron Emission Tomography (PET) with other imaging modalities, such as MRI (Magnetic Resonance Imaging) has allowed for the imaging of cartilage damage, previously thought unreliable.

Nuclear Medicine Imaging Devices: Market Global Market Prospects 2012-2022 report forecasts the size and value of leading national/regional markets including the US, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this diagnostic technology over the forecast period. Developed nuclear medicine markets such as the US and UK are highly saturated and the focus is likely to be towards upgrading stand-alone PET and SPECT system with fully integrated hybrid units, that offer a high level of anatomical and functional detail. Emerging countries such as China and India will offer more opportunity, due a lack of nuclear medicine facilities and technologies, and increased healthcare spending. It has been predicted that healthcare investment in these countries is expected to double in the next seven years.

How will the nuclear medicine imaging systems market develop this decade? Which regions offer the most significant growth opportunities between 2012 and 2022? Which of the nuclear medicine based imaging devices are growing most strongly? Who are the leading companies in the nuclear medicine imaging systems market? What are some promising technological developments in the market? 

This report answers these critical questions and many more through the in-depth analyses that are presented in this report.

Why you should buy Nuclear Medicine Imaging Devices: Global Market Prospects 2012-2022
In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for nuclear medicine imaging systems, with respect to the leading segments, companies and national markets
• You will discover sales trends for the overall nuclear medicine imaging systems market from 2011 to 2022 - seeing where commercial growth will occur
• You will discover sales trends for the Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) market from 2011 to 2022, with detailed discussions of market potential
• You will receive sales forecasts for leading national/regional markets (US, Europe, Japan, India and China), with informed discussion
• You will assess leading manufacturers and products in the nuclear medicine imaging systems market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the nuclear medicine imaging systems market from 2012 onwards
• You will be able to investigate competition and opportunities influencing the nuclear medicine technology from 2012 onwards
• You will see what will stimulate and restrain the market from 2012, with analysis of the recent market trends
• You will discover the unmet needs in the market, driving the growth from 2012 onwards.

Table of Contents

1. Executive Summary

1.1 Sector Highlights
1.2 Aims, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Methods
1.5 Glossary of Terms Related to Report


2. Introduction to Nuclear Medicine

2.1 Nuclear Medicine
2.1.1 History of Nuclear Medicine
2.2 Techniques of Nuclear Medicine
2.2.1 Diagnostic Medical Imaging
2.2.2 Interventional Nuclear Medicine


3. The Nuclear Medicine Market, 2010-2022

3.1 The Global Medical and Diagnostic Imaging Market, 2010
3.1.1 Medical And Diagnostic Imaging: Market Trends 2010-2022
3.2 Nuclear Medicine Market, 2010
3.3 Nuclear Medicine Market Forecast, 2011-2022
3.3.1 Nuclear Medicine: Market Trends, 2012-2022


4. Positron Emission Tomography Market, 2010-2022

4.1 Positron Emission Tomography (PET)
4.1.1 History of PET
4.2 How It Works
4.3 Types of PET Scans
4.3.1 PET/CT
4.3.2 PET/MRI
4.4 Applications of PET
4.5 Limitations of PET
4.6 PET Market, 2010
4.7 PET Market Forecast, 2011-2022
4.7.1 PET: Market Trends, 2012-2022
4.8 PET Devices Currently In Market
4.8.1 GE Healthcare
4.8.2 Philips
4.8.3 Siemens


5. Single Photon Emission Computed Tomography Market, 2010-2022

5.1 Single Photon Emission Computed Tomography (SPECT)
5.1.1 History of SPECT
5.2 How it Works
5.3 Types of SPECT Scans
5.3.1 SPECT/CT
5.3.2 SPECT/MRI
5.4 Applications of SPECT
5.4.1 Cardiology
5.4.2 Neurology
5.4.3 Oncology
5.5 Limitations of SPECT
5.6 SPECT Market, 2010
5.7 SPECT Market Forecast, 2011-2022
5.7.1 SPECT: Market Trends, 2012-2022
5.7.1.1 Cost Effective
5.7.1.2 Hybrid Scanning to Drive SPECT Market
5.7.1.3 Increased Approval of New Radiopharmaceuticals
5.8 SPECT Devices Currently In Market
5.8.1 GE Healthcare
5.8.2 Philips
5.8.3 Siemens


6. Leading Companies In The Nuclear Medicine Market, 2010

6.1 Intensively Competitive Market
6.2 Nuclear Medicine Market: Breakdown by Company, 2010
6.3 GE Healthcare
6.3.1 Sales and Recent Performance Analysis, 2010
6.3.1.1 Technology Sector
6.3.2 New SPECT System Promises Lower Doses
6.4 Siemens Healthcare
6.4.1 Sales And Recent Performance Analysis, 2010
6.4.1.1 Healthcare Sector
6.4.2 New Technology To Provide HD Imaging
6.5 Philips Healthcare
6.5.1 Sales and Recent Performance Analysis, 2010
6.5.1.1 Healthcare Sector
6.5.2 FDA Clearance For Philips Hybrid Technology
6.6 Other Companies


7. Leading National Nuclear Medicine Markets, 2010

7.1 Regional Breakdown of The Global Nuclear Medicine Market, 2010
7.2 The Global Nuclear Medicine Market: Regional Forecast 2012-2022
7.3 The US Market
7.4 The European Market
7.4.1 Germany and France
7.4.2 Italy
7.4.3 Spain
7.4.4 U.K
7.5 The Japanese Market
7.6 The Indian Market
7.7 The Chinese Market


8. SWOT Analysis of the Nuclear Medicine Market, 2012

8.1 Nuclear Medicine: Industry Trends
8.2 Strengths
8.2.1 Patient Demographics
8.2.2 Safer Compared to Competitive Technologies
8.3 Weaknesses
8.3.1 Regulatory Board Approvals
8.3.2 Issues With Protocols
8.3.3 Healthcare Cutbacks
new FieldsetController( 'Order Online Now_details' );

Other users found this report page using the following search terms: PET SPECT nuclear market medicine siemensisused3nuclearimagingisforecasttogrow nuclear imaging trends visiongain siemens 1nuclear 2012

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.

All reports are subject to copyright